Mabwell (Shanghai) Bioscience Co., Ltd. Stock
Equities
688062
CNE100005RD2
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
34.9 CNY | -2.79% | -1.33% | +6.76% |
May. 07 | Mabwell Announces FDA Grants Orphan Drug Designation to 9MW2821 | CI |
Apr. 29 | Mabwell Bioscience Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | 384M 53.21M | Sales 2025 * | 1.11B 153M | Capitalization | 13.95B 1.93B |
---|---|---|---|---|---|
Net income 2024 * | -862M -119M | Net income 2025 * | -594M -82.21M | EV / Sales 2024 * | 36.3 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 12.6 x |
P/E ratio 2024 * |
-16.2
x | P/E ratio 2025 * |
-23.5
x | Employees | 1,491 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 47.33% |
1 day | -2.79% | ||
1 week | -1.33% | ||
Current month | -1.33% | ||
1 month | +2.71% | ||
3 months | +31.60% | ||
6 months | +22.46% | ||
Current year | +6.76% |
Managers | Title | Age | Since |
---|---|---|---|
Da Tao Liu
CEO | Chief Executive Officer | 52 | 17-06-30 |
Jin Hua
DFI | Director of Finance/CFO | 43 | 23-06-26 |
Xin Du
CTO | Chief Tech/Sci/R&D Officer | 52 | 20-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bo Ling Li
BRD | Director/Board Member | 70 | 20-10-10 |
Chun Shan Tang
BRD | Director/Board Member | 55 | 19-03-31 |
Da Tao Liu
CEO | Chief Executive Officer | 52 | 17-06-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 34.9 | -2.79% | 3,066,773 |
24-05-07 | 35.9 | -1.64% | 1,350,862 |
24-05-06 | 36.5 | +3.19% | 3,207,003 |
24-04-30 | 35.37 | -0.67% | 1,324,850 |
End-of-day quote Shanghai S.E., May 07, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+6.76% | 1.93B | |
+2.93% | 108B | |
+8.82% | 105B | |
+1.51% | 23.46B | |
-14.60% | 21.72B | |
-7.05% | 18.64B | |
-38.55% | 17.45B | |
-8.83% | 17.19B | |
+5.51% | 13.99B | |
+37.49% | 12.53B |
- Stock Market
- Equities
- 688062 Stock